BRLS vs YHC

The company exhibits severe financial distress with a Piotroski F-Score of just 1/9, indicating very weak fundamental health. Profitability metrics are deeply negative, with a -65.72% profit margin and -13.56% ROA, while liquidity is critically impaired (Current Ratio: 0.15, Quick Ratio: 0.04). Revenue is declining YoY (-7.60%), and the stock has lost over 90% of its value in the past three years. Despite a low Price/Sales ratio of 0.75, the absence of reliable earnings, cash flow, and balance sheet data, combined with no Graham or Altman scores, suggests extreme risk.

YHC exhibits extreme financial distress, highlighted by a Piotroski F-Score of 0/9, indicating a total lack of fundamental improvement across all health metrics. The company is experiencing a catastrophic collapse in revenue (-64.20% YoY) and suffers from an unsustainable operating margin of -1000.28%. While the company maintains a high current ratio and zero debt, these are overshadowed by massive quarterly earnings misses and a 92% decline from its 52-week high. The combination of negative growth, zero profitability, and a bearish technical trend suggests a high risk of further capital erosion.